SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-19-006945
Filing Date
2019-09-16
Accepted
2019-09-16 07:05:23
Documents
24
Period of Report
2019-09-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_091619.htm 8-K 17696
2 PRESS RELEASE ex99-01.htm EX-99.01 12774
3 CORPORATE PRESENTATION BY THE COMPANY ex99-02.htm EX-99.02 34301
4 GRAPHIC ex99-02_img01.jpg GRAPHIC 57703
5 GRAPHIC ex99-02_img02.jpg GRAPHIC 217828
6 GRAPHIC ex99-02_img03.jpg GRAPHIC 120404
7 GRAPHIC ex99-02_img04.jpg GRAPHIC 145330
8 GRAPHIC ex99-02_img05.jpg GRAPHIC 135516
9 GRAPHIC ex99-02_img06.jpg GRAPHIC 113061
10 GRAPHIC ex99-02_img07.jpg GRAPHIC 156574
11 GRAPHIC ex99-02_img08.jpg GRAPHIC 186809
12 GRAPHIC ex99-02_img09.jpg GRAPHIC 125945
13 GRAPHIC ex99-02_img10.jpg GRAPHIC 127396
14 GRAPHIC ex99-02_img11.jpg GRAPHIC 125364
15 GRAPHIC ex99-02_img12.jpg GRAPHIC 137822
16 GRAPHIC ex99-02_img13.jpg GRAPHIC 161762
17 GRAPHIC ex99-02_img14.jpg GRAPHIC 127114
18 GRAPHIC ex99-02_img15.jpg GRAPHIC 134636
19 GRAPHIC ex99-02_img16.jpg GRAPHIC 116359
20 GRAPHIC ex99-02_img17.jpg GRAPHIC 165266
21 GRAPHIC ex99-02_img18.jpg GRAPHIC 158318
22 GRAPHIC ex99-02_img19.jpg GRAPHIC 153674
23 GRAPHIC ex99-02_img20.jpg GRAPHIC 102522
24 GRAPHIC ex99-02_img21.jpg GRAPHIC 44717
  Complete submission text file 0001387131-19-006945.txt   3944493
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 191093734
SIC: 2834 Pharmaceutical Preparations